{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:21:01Z","timestamp":1769559661831,"version":"3.49.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1997,9]]},"DOI":"10.1212\/wnl.49.3.714","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:29:58Z","timestamp":1336915798000},"page":"714-717","source":"Crossref","is-referenced-by-count":97,"title":["Altered systemic iron metabolism in Parkinson's disease"],"prefix":"10.1212","volume":"49","author":[{"given":"G.","family":"Logroscino","sequence":"first","affiliation":[{"name":"From the Gertrude H. Sergievsky Center (Drs. Logroscino, Marder, Cote, and Mayeux); the Departments of Neurology (Drs. Logroscino, Marder, Cote, and Mayeux), Psychiatry (Dr. Mayeux), and Pharmacology (Dr. Graziano), College of Physicians and Surgeons; Divisions of Epidemiology (Dr. Mayeux) and Environmental Health Sciences (Drs. Graziano and Freyer, and V. Slavkovich and N. LoIacono), School of Public Health, Columbia University, New York, NY; and Divisione di Neurologia (Dr. Logroscino), Ospedale..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Marder","sequence":"additional","affiliation":[{"name":"From the Gertrude H. Sergievsky Center (Drs. Logroscino, Marder, Cote, and Mayeux); the Departments of Neurology (Drs. Logroscino, Marder, Cote, and Mayeux), Psychiatry (Dr. Mayeux), and Pharmacology (Dr. Graziano), College of Physicians and Surgeons; Divisions of Epidemiology (Dr. Mayeux) and Environmental Health Sciences (Drs. Graziano and Freyer, and V. Slavkovich and N. LoIacono), School of Public Health, Columbia University, New York, NY; and Divisione di Neurologia (Dr. Logroscino), Ospedale..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Graziano","sequence":"additional","affiliation":[{"name":"From the Gertrude H. Sergievsky Center (Drs. Logroscino, Marder, Cote, and Mayeux); the Departments of Neurology (Drs. Logroscino, Marder, Cote, and Mayeux), Psychiatry (Dr. Mayeux), and Pharmacology (Dr. Graziano), College of Physicians and Surgeons; Divisions of Epidemiology (Dr. Mayeux) and Environmental Health Sciences (Drs. Graziano and Freyer, and V. Slavkovich and N. LoIacono), School of Public Health, Columbia University, New York, NY; and Divisione di Neurologia (Dr. Logroscino), Ospedale..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Freyer","sequence":"additional","affiliation":[{"name":"From the Gertrude H. Sergievsky Center (Drs. Logroscino, Marder, Cote, and Mayeux); the Departments of Neurology (Drs. Logroscino, Marder, Cote, and Mayeux), Psychiatry (Dr. Mayeux), and Pharmacology (Dr. Graziano), College of Physicians and Surgeons; Divisions of Epidemiology (Dr. Mayeux) and Environmental Health Sciences (Drs. Graziano and Freyer, and V. Slavkovich and N. LoIacono), School of Public Health, Columbia University, New York, NY; and Divisione di Neurologia (Dr. Logroscino), Ospedale..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Slavkovich","sequence":"additional","affiliation":[{"name":"From the Gertrude H. Sergievsky Center (Drs. Logroscino, Marder, Cote, and Mayeux); the Departments of Neurology (Drs. Logroscino, Marder, Cote, and Mayeux), Psychiatry (Dr. Mayeux), and Pharmacology (Dr. Graziano), College of Physicians and Surgeons; Divisions of Epidemiology (Dr. Mayeux) and Environmental Health Sciences (Drs. Graziano and Freyer, and V. Slavkovich and N. LoIacono), School of Public Health, Columbia University, New York, NY; and Divisione di Neurologia (Dr. Logroscino), Ospedale..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"LoIacono","sequence":"additional","affiliation":[{"name":"From the Gertrude H. Sergievsky Center (Drs. Logroscino, Marder, Cote, and Mayeux); the Departments of Neurology (Drs. Logroscino, Marder, Cote, and Mayeux), Psychiatry (Dr. Mayeux), and Pharmacology (Dr. Graziano), College of Physicians and Surgeons; Divisions of Epidemiology (Dr. Mayeux) and Environmental Health Sciences (Drs. Graziano and Freyer, and V. Slavkovich and N. LoIacono), School of Public Health, Columbia University, New York, NY; and Divisione di Neurologia (Dr. Logroscino), Ospedale..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cote","sequence":"additional","affiliation":[{"name":"From the Gertrude H. Sergievsky Center (Drs. Logroscino, Marder, Cote, and Mayeux); the Departments of Neurology (Drs. Logroscino, Marder, Cote, and Mayeux), Psychiatry (Dr. Mayeux), and Pharmacology (Dr. Graziano), College of Physicians and Surgeons; Divisions of Epidemiology (Dr. Mayeux) and Environmental Health Sciences (Drs. Graziano and Freyer, and V. Slavkovich and N. LoIacono), School of Public Health, Columbia University, New York, NY; and Divisione di Neurologia (Dr. Logroscino), Ospedale..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mayeux","sequence":"additional","affiliation":[{"name":"From the Gertrude H. Sergievsky Center (Drs. Logroscino, Marder, Cote, and Mayeux); the Departments of Neurology (Drs. Logroscino, Marder, Cote, and Mayeux), Psychiatry (Dr. Mayeux), and Pharmacology (Dr. Graziano), College of Physicians and Surgeons; Divisions of Epidemiology (Dr. Mayeux) and Environmental Health Sciences (Drs. Graziano and Freyer, and V. Slavkovich and N. LoIacono), School of Public Health, Columbia University, New York, NY; and Divisione di Neurologia (Dr. Logroscino), Ospedale..."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"1","volume":"114","year":"1991","unstructured":"Dexter DT, Carayon A, Javoy-Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991;114:1953-1975.","journal-title":"Brain"},{"key":"e_1_3_1_3_2","first-page":"7","volume":"65","year":"1995","unstructured":"Connor JR, Synder BS, Arosio P, Loeffler DA, LeWitt P. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J Neurochem 1995;65:717-724.","journal-title":"J Neurochem"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb08813.x"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.1.9"},{"key":"e_1_3_1_6_2","first-page":"7","volume":"63","year":"1994","unstructured":"Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994;63:793-807.","journal-title":"Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem"},{"key":"e_1_3_1_7_2","first-page":"8","volume":"142","year":"1995","unstructured":"Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1995;142:820-827.","journal-title":"Am J Epidemiol"},{"key":"e_1_3_1_8_2","first-page":"1","volume":"55","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.1.1"},{"key":"e_1_3_1_10_2","unstructured":"Diagnostic and statistical manual of mental disorders. 3rd ed revised. Washington DC: American Psychiatric Association 1987;205-224."},{"key":"e_1_3_1_11_2","first-page":"5","volume":"122","year":"1985","unstructured":"Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65.","journal-title":"Am J Epidemiol"},{"key":"e_1_3_1_12_2","first-page":"8","volume":"39","year":"1996","unstructured":"Logroscino G, Marder K, Cote L, Tang M-X, Shea S, Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Ann Neurol 1996;39:89-94.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_13_2","first-page":"3","volume":"20","year":"1974","unstructured":"Yeh Y-Y, Zee P. Micromethod for determining total iron-binding capacity by flameless atomic absorption spectrophotometry. Clin Chem 1974;20:360-364.","journal-title":"Clin Chem"},{"key":"e_1_3_1_14_2","first-page":"2","volume":"61","year":"1974","unstructured":"Miles L, Lipschitz D, Bieter CP, Cook JD. Measurements of serum ferritin by a 2-site immunoradiometric assay. Anal Chem 1974;61:209-224.","journal-title":"Anal Chem"},{"key":"e_1_3_1_15_2","first-page":"5","volume":"47","year":"1990","unstructured":"Greene RJ, Hall AD, Hider RC. The interaction of orally administered iron with levodopa and methyldopa therapy. J Pharm Pharmacol 1990;47:502-504.","journal-title":"J Pharm Pharmacol"},{"key":"e_1_3_1_16_2","first-page":"2","volume":"45","year":"1989","unstructured":"Campbell NRC, Hasinoff B. Ferrous sulfate reduces levodopa bioavailability: chelation as a possible mechanism. Clin Pharmacol Ther 1989;45:220-225.","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_3_1_17_2","first-page":"5","volume":"30","year":"1990","unstructured":"Campbell NRC, Rankine D, Goodridge AE, Hasinoff BB, Kara M. Sinemet-ferrous sulfate interaction in patients with Parkinson's disease. Br J Clin Pharmacol 1990;30:599-605.","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198807073190101"},{"key":"e_1_3_1_19_2","first-page":"8","volume":"125","year":"1994","unstructured":"Cabrera-Valdivia F, Jim\u00e9nez-Jim\u00e9nez FJ, Molina JA, et al. Peripheral iron metabolism in patients with Parkinson's disease. J Neurol Sci 1994;125:82-86.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_20_2","first-page":"8","volume":"46","year":"1992","unstructured":"Abbott RA, Cox M, Markus H, Tomkins A. Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr 1992;46:879-884.","journal-title":"Eur J Clin Nutr"},{"key":"e_1_3_1_21_2","first-page":"5","volume":"52","year":"1990","unstructured":"Looker J, Sempos C, Liu K, Johnson C, Gunter E. Within person variance of biochemical indicators of iron status: effects on prevalence estimates. Am J Clin Nutr 1990;52:541-547.","journal-title":"Am J Clin Nutr"},{"key":"e_1_3_1_22_2","first-page":"4","volume":"20","year":"1994","unstructured":"Morris CM, Candy JM, Omar S, Bloxham CA, Edwardson JA. Transferrin receptors in the Parkinsonian midbrain. Neuropathol Appl Neurobiol 1994;20:468-472.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"e_1_3_1_23_2","first-page":"1","volume":"72","year":"1993","unstructured":"Klausner RD, Rouault TA, Harford JB. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 1993;72:19-28.","journal-title":"Cell"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","unstructured":"Jaffrey SR Haile DJ Klausner RD Harford JB. The interaction between the iron-responsive element binding protein and its cognate RNA is highly dependent upon both RNA sequence and structure. Nucleic Acids Res 1993;4627-4631.","DOI":"10.1093\/nar\/21.19.4627"},{"key":"e_1_3_1_25_2","first-page":"8","volume":"64","year":"1991","unstructured":"Rouault TA, Stout CD, Kaptain S, Harford JB, Klausner RD. Structural relationship between iron-regulated RNA-binding protein(IRE-BP) and aconitase: functional implications. Cell 1991;64:881-883.","journal-title":"Cell"},{"key":"e_1_3_1_26_2","first-page":"4","volume":"270","year":"1995","unstructured":"Kim H, Klausner R, Rouault T. Translational repressor activity is equivalent and is quantitatively predicted by in vitro RNA binding for two iron-responsive element binding proteins. IRP1 and IRP2. J Biol Chem 1995;270:4983-4986.","journal-title":"J Biol Chem"},{"key":"e_1_3_1_27_2","first-page":"8","volume":"67","year":"1996","unstructured":"Hu J, Connor JR. Demonstration and characterization of the iron regulatory protein in human brain. J Neurochem 1996;67:838-844.","journal-title":"J Neurochem"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.49.3.714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:39:30Z","timestamp":1711553970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.49.3.714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["10.1212\/WNL.49.3.714"],"URL":"https:\/\/doi.org\/10.1212\/wnl.49.3.714","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}